Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2020 Oct 1;105(10):3234-3242.
doi: 10.1210/clinem/dgaa436.

Increased Body Mass Index Is Associated With A Nondilutional Reduction in Antimüllerian Hormone

Affiliations
Multicenter Study

Increased Body Mass Index Is Associated With A Nondilutional Reduction in Antimüllerian Hormone

Eleni Greenwood Jaswa et al. J Clin Endocrinol Metab. .

Abstract

Context: Controversy exists regarding if and how body mass index (BMI) impacts antimüllerian hormone (AMH) in women with and without polycystic ovary syndrome (PCOS). Understanding the BMI-AMH relationship has critical implications for clinical interpretation of laboratory values and could illuminate underlying ovarian physiology.

Objective: To test the hypotheses that (1) BMI is associated with reduced AMH in PCOS and ovulatory controls (OVAs) and (2) the reduction in AMH is not accounted for by dilutional effects.

Design/setting: Multicenter cohort.

Participants: Women aged 25 to 40 years from 2 clinical populations: 640 with PCOS, 921 women as OVAs.

Main outcome measures: Ovarian reserve indices: AMH, antral follicle count (AFC), and AMH to AFC ratio (AMH/AFC) as a marker of per-follicle AMH production.

Results: In both cohorts, increasing BMI and waist circumference were associated with reductions in AMH and AMH/AFC, after adjusting for age, race, smoking, and site in multivariate regression models. Increasing BMI was associated with reduced AFC in PCOS but not OVAs. Body surface area (BSA), which unlike BMI is strongly proportional to plasma volume, was added to investigate a potential dilutive effect of body size on AMH concentrations. After controlling for BSA, BMI retained independent associations with AMH in both cohorts; BSA no longer associated with AMH.

Conclusions: In an adjusted analysis, BMI, but not BSA, was associated with reduced AMH; these data do not support a role for hemodilution in mediating the relationship between increased body size and reduced AMH. Decreased AMH production by the follicle unit may be responsible for reduced AMH with increasing BMI.

Keywords: antimüllerian hormone; antral follicle count; obesity; ovarian reserve; polycystic ovary syndrome.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Changes in ovarian reserve measures (AMH, AFC) with increasing BMI. The relationship between BMI and ovarian reserve measures (AMH, AFC) is depicted, with data from the women with PCOS in the left hand column and data from the ovulatory controls (OVA) in the right hand column. AFC, antral follicle count; AMH, antimüllerian hormone; BMI, body mass index; coeff, coefficient; OVA, ovarian aging control cohort; PCOS, polycystic ovary syndrome.

References

    1. Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril. 2012;98(6):1407-1415. - PubMed
    1. Broekmans FJ, Soules MR, Fauser BC. Ovarian aging: mechanisms and clinical consequences. Endocr Rev. 2009;30(5): 465-493. - PubMed
    1. Greenwood EA, Cedars MI, Santoro N, et al. ; National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development Cooperative Reproductive Medicine Network . Antimüllerian hormone levels and antral follicle counts are not reduced compared with community controls in patients with rigorously defined unexplained infertility. Fertil Steril. 2017;108(6):1070-1077. - PubMed
    1. Rosen MP, Johnstone E, McCulloch CE, et al. A characterization of the relationship of ovarian reserve markers with age. Fertil Steril. 2012;97(1):238-243. - PMC - PubMed
    1. Dewailly D, Andersen CY, Balen A, et al. The physiology and clinical utility of anti-mullerian hormone in women. Hum Reprod Update. 2014;20(3):370-385. - PubMed

Publication types

Substances